Effect of COVID-19 (SARS-CoV-2) Vaccination on Patients with Atopic Dermatitis Treated with Dupilumab: A Multicenter, Observational Study

BACKGROUND: Atopic dermatitis (AD) patients usually wonder if their condition will worsen after vaccination or if they should continue with the treatment they are receiving. Considering that many patients treated with dupilumab had previously experienced severe AD symptoms and flares, the concerns a...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Tae Young, Shim, Dong Hyun, Lee, Yu Jin, Lee, Young Bok, Koo, Ha Yeh Rin, Shin, Min Kyung, Kim, Tae Eun, Jang, Yong Hyun, Bang, Jin Seon, Kook, Hyung Don, Ahn, Jiyoung, Jung, Hye Jung, Na, Chan Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905853/
https://www.ncbi.nlm.nih.gov/pubmed/36750457
http://dx.doi.org/10.5021/ad.22.118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905853/
https://www.ncbi.nlm.nih.gov/pubmed/36750457
http://dx.doi.org/10.5021/ad.22.118

Ejemplares similares